Breast Cancer Prognostic Biomarkers: Transcriptome & Proteome Analysis

Integrating the transcriptome and proteome reveals two prognostic biomarkers for breast cancer, particularly for the estrogen receptor positive subset.

Proteogenomic Analysis of Breast Cancer Transcriptomic and Proteomic Data, Using De Novo Transcript Assembly: Genome-Wide Identification of Novel Peptides and Clinical Implications - ScienceDirect

Integrative transcriptome and proteome analyses of clear cell renal cell carcinoma develop a prognostic classifier associated with thrombus

Novel Genetic and Epigenetic Biomarkers of Prognostic and Predictive Significance in Stage II/III Colorectal Cancer: Molecular Therapy

Frontiers Integrated Transcriptome and Pathway Analyses Revealed Multiple Activated Pathways in Breast Cancer

Proteomic analysis of circulating extracellular vesicles identifies potential markers of breast cancer progression, recurrence, and response

Druggable proteome analysis. a Correlation matrix of all 290 FDA

Frontiers Integrative Analysis of Membrane Proteome and MicroRNA Reveals Novel Lung Cancer Metastasis Biomarkers

Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes

Transcriptome profiling and proteomic validation reveals targets of the androgen receptor signaling in the BT-474 breast cancer cell line, Clinical Proteomics

Proteomic-based stratification of intermediate-risk prostate cancer patients

Proteomes, Free Full-Text

Cells, Free Full-Text

Cancers, Free Full-Text

Harnessing the modified proteome for increased diagnostic power - Drug Discovery World (DDW)

Screening and predicted value of potential biomarkers for breast cancer using bioinformatics analysis